| Literature DB >> 29713283 |
Yue Liu1,2, Qi Wang2, Jianbo Yang2, Xiaohan Guo2, Wenxi Liu2, Shuangcheng Ma2,3, Shaoping Li4.
Abstract
Polygonum multiflorum Thunb. and its processed products have been used in China for centuries due to their multiple beneficial effects to human body. Currently, liver injuries caused by taking P. multiflorum have been reported worldwide, but the potential toxic components and possible mechanism that caused hepatotoxicity remain unclear. It is worth noting that the processing procedure could significantly decrease the toxicity of raw P. multiflorum and the processed products of P. multiflorum are considered to be relatively safe. However, the processing mechanism is still ambiguous, and there is the lack of a scientific approach to control the quality of P. multiflorum praeparata. This study is the first review that summarizes the recently advances (from 2007 to 2017) in the chemical analysis of P. multiflorum, and provides comprehensive information on the quantitative and qualitative analysis of P. multiflorum as well as its related species. In addition, the processing mechanism and quality evaluation of processed P. multiflorum are discussed. Moreover, the toxicity of P. multiflorum is analyzed from the perspectives of exploration of the proposed toxic ingredients, metabolite identification, metabolomics studies, and exogenous contaminant determination. Furthermore, trends and perspectives for future research of this medicine are discussed.Entities:
Keywords: Polygonum multiflorum thunb.; anthraquinones; chemical analysis; hepatotoxicity; processing mechanism; quality evaluation; review; stilbene glucosides
Year: 2018 PMID: 29713283 PMCID: PMC5912012 DOI: 10.3389/fphar.2018.00364
Source DB: PubMed Journal: Front Pharmacol ISSN: 1663-9812 Impact factor: 5.810
Overview of PM-related reviews since 2007.
| Traditional usages and botany | Bounda and Feng, |
| Phytochemistry/Bioactive compounds | Bounda and Feng, |
| Pharmacology | Bounda and Feng, |
| Clinical studies/Hepatotoxicity case reports | Zhang et al., |
| Side effect and safety | Shaw, |
| Pharmacokinetics | Bounda and Feng, |
| TSG | Ling and Xu, |
| Emodin | Dong et al., |
| Rhein | Zhou et al., |
Quality standards recorded in Chinese pharmacopeia.
| PM | TSG | Eluted with acetonitrile: water (25: 75) | 320 nm | TSG not <1.0% |
| Emodin and Physcion | Eluted with methanol: 0.1% formic acid aqueous solution (80: 20) | 254 nm | Combined anthraquiones not <0.10% | |
| PMP | TSG | Eluted with acetonitrile: water (25: 75) | 320 nm | TSG not <0.70% |
| Emodin and Physcion | Eluted with methanol: 0.1% formic acid aqueous solution (80: 20) | 254 nm | Free anthraquinones not <0.10% | |
| TSG | Eluted with acetonitrile: water (26: 74) | 320 nm | TSG not <0.20% |
indirect quantification.
direct quantification.
Figure 1Chemical structures of stilbenes, anthraquinones and flavonoids.
Figure 2Chemical structures of nucleosides and other compounds.
Chromatographic approaches for the qualitative analysis of PM.
| HPLC-IT-MS | 12 glycosides including 3 newly reported | Crude root | Eluted with CH3OH: 10 mM CH3COONH4 (0 min: 0:100; 20 min: 30:70; 50 min: 95:5; 60 min: 95:5) on an Ultimate XB-C18 column | Sun et al., |
| HPLC-ESI-MS | 11 compounds including 2 unknowns | Crude root | Eluted with H2O: CH3CN (both of them containing 0.5% CH3COOH) (0 min: 90:10; 35 min: 60:40; 50 min: 0:100) on an Alltima C18 column | Yi et al., |
| HPLC-ESI-MS | 7 compounds | Caulis | Eluted with CH3CN: H2O (containing 0.5% HCOOH) (0 min: 0:100; 22 min: 16:84; 45 min: 34:66; 60 min: 38:62; 70 min: 95:5; 80 min: 95:5) on a Grace Alltima C18 column | Zhao et al., |
| UPLC-Q-TOF-MS | 29 components including 8 newly reported | Crude root | Eluted with CH3OH: H2O (both of them containing 0.1% CH3COOH) (0 min: 0:100; 25 min: 35:65; 40 min: 70:30; 50 min: 100:0; 53 min: 100:0; 53.1 min: 0:100; 60 min: 0:100) on a Phenomenex Hydro-RP C18 column | Lin et al., |
| UHPLC-Q-TOF-MS | 131 compounds including 26 unknowns | Crude root | Eluted with CH3CN: H2O (containing 0.1% CH3COOH) (0 min: 97:3; 20 min: 3:97) on a T3 C18 column | Wang et al., |
| HPLC-LTQ-Orbitrap-MS | 28 new dianthrone glycosides | Crude root | Eluted with CH3CN: H2O (containing 0.1% HCOOH) (0 min: 5:95; 6 min: 15:85; 12 min: 15:85; 25 min: 38:62; 30 min: 70:30) on a Hypersil Gold C18 column | Xu et al., |
| UHPLC-LTQ-Orbitrap-MS | 59 phenolic compounds including 12 newly reported | Crude root | Eluted with CH3CN: H2O (containing 0.1% HCOOH) (0 min: 5:95; 6 min: 15:85; 12 min: 15:85; 25 min: 38:62; 30 min: 70:30; 35 min: 90:10) on a Hypersil Gold C18 column | Qiu et al., |
| UHPLC-LTQ-Orbitrap-MS | 25 compounds | Crude and processed root | Eluted with CH3CN: H2O (containing 0.1% HCOOH) (0 min: 13:87; 3.5 min: 35:65; 7.5 min: 90:10; 8.5 min: 95:5; 10 min: 95:5) on an AcQuity UPLC™ BEH C18 column | Wang T. H. et al., |
Quantitative analysis methods of PM.
| HPLC-PDA (290, 320 nm) | TSG, emodin, physcion, EMG, PG | Crude root | Eluted with H2O: CH3CN (both of them containing 0.5% CH3COOH) (0 min: 90:10; 35 min: 60:40; 50 min: 0:100) on an Alltima C18 column | Yi et al., |
| HPLC-PDA (254 nm) | emodin, physcion, aloe-emodin, rhein, chrysophanol | Crude root | Eluted with CH3OH: H2O: H3PO4 (0 min: 600:400:1; 80 min: 600:400:1) on an Agilent C18 reversed-phase column | Jiao and Zuo, |
| HPLC-UV (254, 320 nm) | TSG, emodin, physcion | Crude root | Eluted with CH3CN: H2O (25:75) on a Diamond C18 analytical column; Eluted with CH3OH: 0.1% H3PO4 (85:15) on a Diamond C18 analytical column | Yan et al., |
| HPLC-DAD (210, 280, 320 nm) | TSG, EMG, gallic acid, catechin, epicatechin, proanthocyanidin B1 and B2, hypaphorine | Crude root, rhizome, stem | Eluted with CH3CN: H2O (containing 0.05% H3PO4) (0 min: 0:100; 7 min: 6:94; 12 min: 6:94; 20 min: 8:92; 22 min: 12:88; 50 min: 25:75) on a Zorbax SB-AQ column | Han et al., |
| HPLC-UV (254, 320 nm) | TSG, emodin, physcion | Crude root | Eluted with CH3OH: H2O (containing 0.1% H3PO4) (30:70) and (80:20) on a Waters Nova-Pak C18 column, respectively | Liang et al., |
| HPLC-UV (254, 320 nm) | TSG, emodin, physcion | Crude root | Eluted with CH3CN: H2O (25:75) and CH3OH: H2O (containing 0.1% H3PO4) (80:20) on a SinoChrom ODS BP C18 RP column, respectively | Li et al., |
| UPLC-PDA (280, 320 nm) | TSG, EMG, emodin, physcion | Crude and processed root | Eluted with H2O: CH3CN (both of them containing 0.3% CH3COOH) (0 min: 85:15; 2 min: 85:15; 3 min: 75:25; 5 min: 70:30; 6 min: 15:85; 7 min: 0:100) on an Acquity BEH C18 column | Han et al., |
| HPLC-PDA (290 nm) | TSG, emodin, physcion | Caulis | Eluted with CH3CN: H2O (containing 0.5% HCOOH) (0 min: 0:100; 22 min: 16:84; 45 min: 34:66; 60 min: 38:62; 70 min: 95:5; 80 min: 95:5) on a Grace Alltima C18 column | Zhao et al., |
| HPLC-MS | TSG, emodin, physcion | Crude root | Eluted with CH3CN: H2O (both of them containing 0.5% CH3COOH) (0 min: 10:90; 45 min: 35:65; 65 min: 100:0) on an Alltima C18 analytical column | Liang et al., |
| HPLC-MS/MS | TSG, emodin, physcion, gallic acid, resveratrol, polydatin, catechin, epicatechin | Crude and processed root | Eluted with CH3CN: H2O (containing 0.05% HCOOH) (0 min: 10:90; 10 min: 60:40; 15 min: 90:10; 17 min: 10:90; 20 min: 10:90) on an Eclipse Plus C18 column | Zhu et al., |
| HPLC-MS/MS | TSG, emodin, physcion, EMG, RHG, resveratrol, polydatin, catechin, rutin, epicatechin, gallic acid, rhaponiticin, hyperin, p-hydraxy benzaldehyde | Crude root | Eluted with CH3OH: H2O (both of them containing 0.1% HCOOH) (0 min: 20:80; 2 min: 40:60; 4 min: 50:50; 6 min: 60:40; 8 min: 70:30; 10 min: 80:20; 12 min: 100:0; 15 min: 100:0; 15.1 min: 0:100; 20 min: 20:80) on a Phenomenex Hydro-RP C18 column | Lin et al., |
| UHPLC-LTQ-Orbitrap-MS | TSG, EMG, emodin, gallic acid | Crude and processed root | Eluted with CH3CN: H2O (containing 0.1% HCOOH) (0 min: 13:87; 3.5 min: 35:65; 7.5 min: 90:10; 8.5 min: 95:5; 10 min: 95:5) on an AcQuity UPLC™ BEH C18 column | Wang T. H. et al., 2015 |
| UPLC-MS/MS | TSG, EMG, aloe-emodin, emodin, rhein, physcion, resveratrol, polydatin, rutin, epicatechin, gallic acid, quercetin, astraglin, hyperoside | Crude root | Eluted with CH3CN: H2O (containing 0.1% HCOOH) (0 min: 100:0; 1 min: 90:10; 2 min: 10:90; 3 min: 10:90; 4 min: 90:10; 5 min: 90:10) on a Waters BEH C18 column | Luo et al., |
| Capillary-GC-FID-MS | emodin, physcion, aloe-emodin, rhein, chrysophanol | Crude root | The temperature program was 0 min: 180°C; 1 min: 180°C; 11 min: 300°C; 21min: 300°C on a ECTM-5 capillary column | Zuo et al., |
| MEKC (210 nm) | TSG, proanthocyanidin B1 and B2, gallic acid, catechin, epicatechin, hypaphorine | Crude root | Optimum separation was obtained within 14 min by using 50 mM phosphate buffer containing 90 mM SDS and 2% (m/v) HP-β-CD (pH 2.5) at 15 kV and 20°C | Lao et al., |
Comparative analysis methods of PM-related medicinal plants.
| HPLC-VWD/DAD (254, 280, 320 nm) | TSG, emodin, physcion, aloe-emodin, rhein, chrysophanol, EMG, piceid, resveratrol, epicatechin, gallic acid, sennoside A and B | PM, PC, and RO | Eluted with CH3CN: H2O (containing 0.05% HCOOH) (0 min: 5:95; 2 min: 10:90; 4 min: 15:85; 10 min: 15:85; 11 min: 21:79; 14 min: 21:79; 21 min: 29:71; 23 min: 40:60; 25 min: 50:50; 26 min: 50:50; 28 min: 80:20; 30 min 100:0; 32 min: 100:0) on an Agilent Zorbax Stable Bond-C18 column | Ma et al., |
| HPLC-PDA (280, 320 nm) | polydatin, resveratrol, aloe-emodin, rhein, emodin, physcion, danthron, chrysophanol | PM, PC, | Eluted with H2O: CH3CN (both containing 0.1% CH3COOH) (0 min: 80:20; 35 min: 0:100) on a Phenomenex Gemini C18 column | Avula et al., |
| HPLC-DAD-ESI/MS (290 nm) | TSG, rhaponticoside, resveratrol, piceid, aloe-emodin, emodin, physcion, rhein, chrysophanol, EMG, PG, TOG, EMG1, CHG | PM, RO, and | Eluted with H2O: CH3CN (0 min: 85:15; 10 min: 80:20; 40 min: 47:53; 60 min: 0:100) on an Alltima C18 column | Feng et al., |
| HPLC-DAD-ESI/MSn (290 nm) | TSG, | PM and PC | Eluted with CH3CN: H2O (containing 0.1% HCOOH) (0 min:22:78; 1.5 min: 30:70; 6 min: 65:35; 8 min: 90:10; 9 min: 90:10) on a Kinetex C18 column | Li et al., |
| HPLC- fluorescence detection (440, 540 nm) | emodin, physcion, rhein, aloe-emodin, chrysophanol | PM and PC | Eluted with CH3OH: H2O (containing 0.1% HCOOH) (0 min: 85:15; 15 min: 85:15) on a Hypersil C18 column | He et al., |
| NMR | Fingerprint analysis | PM and PC | Performed on a Bruker Avance 500 MHz NMR spectrometer operating at 500.13 MHz | Frederich et al., |
Hepatotoxic analysis of PM in vivo and in vitro.
| HPLC-DAD (290 nm) | TSG, EG, PG, emodin, physcion, chrysophanol | Mice, p.o., repeated 28 days (5, 10 and 20 g/kg/day of water and acetone extracts of PM and PMP, respectively), blood samples, histopathologic examination and biochemical analysis | Eluted with CH3CN: H2O (0 min: 10:90; 35 min: 40:60; 60 min: 100:0) on a hypersil C18 column | Wu et al., |
| HPLC-MS | TSG, emodin, EG | Rats, p.o., repeated 21 days (1 and 20 g/kg/day of 80% ethanol extractions of PM), blood samples and tissues, histopathologic examination and biochemical analysis | Eluted with CH3CN: H2O (containing 0.1% HCOOH) (0 min: 20:80; 3.5 min: 35:65; 4.5 min: 35:65; 6 min: 40:60; 7 min: 40:60; 8 min: 100:0; 11 min: 100:0) On an Agilent Extend-C18 column | Ma J. et al., |
| HPLC-MS | TSG, emodin | Rats, p.o. repeated 7 days (TSG, 117 mg/kg), on the 8th day, p.o. (emodin 82.4 mg/kg), blood samples | Eluted with CH3CN: H2O (containing 0.1% HCOOH) (0 min: 70:30; 2 min:70:30) On an Agilent Extend-C18 column | Ma et al., |
| HPLC-DAD (254 nm) | TSG, emodin, physcion | Human hepatocytes cell L-02, treated with serial concentrations of water, 50% and 95% ethanol extracts of PM and PMP (20~100 μg/mL, respectively), MTT assay | Eluted with CH3OH: H2O (containing 0.1% H3PO4) (0 min: 40:60; 5 min: 70:30; 10 min: 80:20; 15min: 85:15; 20min: 90:10; 25 min: 90:10) On a Zorbax SB-C18 analytical column. | Yu et al., |
| HPLC-DAD (210, 280, 320 nm) | 15 components | Human hepatocytes cell L-02, treated with serial concentrations of water and ethanol extracts of PM (0, 0.5, 1, 2.5, 5 mg/mL, respectively), MTT assay | Eluted with CH3CN: H2O (containing 0.1% HCOOH) (0 min: 6:94; 7 min: 6:94; 12 min: 6:94; 20 min: 8:92; 22 min: 12:88; 50 min: 25:75; 55 min: 0:100) on a Zorbax SB-AQ C18 column | Lv et al., |
| UPLC-Q-TOF-MS | Non-targeted | Human hepatocytes cell L-02, treated with serial concentrations of water and ethanol extracts of PM and PMP (7.81~1,000.0 μg/mL, respectively), MTT assay | Eluted with CH3CN: H2O (both of them containing 0.1% HCOOH) (0 min: 0:100; 3 min: 10:90; 10 min: 20:80; 20 min: 70:30; 21 min: 100:0; 21.1 min: 0:100; 25 min: 0:100) on an ACQUITY UPLC HSS T3 column | Lin et al., |
| HPLC-MS | emodin | Human hepatocytes cell L-02, treated with serial concentrations of emodin (0, 10, 20, 40, 60, 120 μM), Cell Counting Kit (CCK)-8 assay | Eluted with CH3CN: H2O (containing 0.2% HCOOH) (0 min: 45:55; 15 min: 30:70) On a C18 column | Li et al., |
| UPLC-MS | emodin | Human hepatocytes cell L-02, treated with serial concentrations of emodin (10~120 μM), MTT assay | Eluted with CH3CN: H2O (containing 0.1% HCOOH) (0 min: 5:95; 3 min: 50:50; 15 min: 100:0; 20 min: 100:0; 21 min: 5:95; 26 min: 5:95) On a Zorbax Eclipse plus C18 column | Liu et al., |
Metabolomics analysis of PM.
| LC-MS | GDCA, HDCA | bile acids metabolism | Rats, p.o., repeated 42 days (50 g/kg/day of 75% ethanol extracts of PM and PMP, respectively), blood and bile samples | Eluted with CH3OH (containing 0.1% HCOOH): H2O (containing 0.1% HCOOH and 1mM CH3COONH4) (0 min: 70:30; 3 min: 80:20; 8 min: 90:10; 8.5 min: 95:5; 14.4 min: 100:0; 14.5 min: 70:30; 20 min: 70:30) On a Ulimate C18 column | Dong et al., |
| GC-MS | 18 biomarkers | amino acid, lipid and energy metabolism | Rats, p.o., repeated 28 days (30 g/kg/day of water and 80% ethanol extracts of PM, respectively), blood and liver tissues | The temperature program was 0–5 min: 80°C, 6–23 min: 80–260°C, 24–34 min: 260°C, on a HP-5MS column | Zhang et al., |
| GC-MS | 10 biomarkers | amino acid, fatty acid, and energy metabolism | Rats, p.o., repeated 28 days (19.2, 192, and 1920 mg/kg/day of 95% ethanol extracts of PM), serum samples | The temperature program was 0–25 min: 80–280°C, 25–29 min: 280°C, on a DB-5MS column | Xia et al., |
| LC-MS | 16 biomarkers | vitamin and tryptophan metabolism, citrate cycle | Rats, p.o., repeated 28 days (20 g/kg/day of 75% ethanol extractions of PM and PMP, respectively), urine samples | Eluted with CH3OH : H2O (0 min: 30:70; 5 min: 90:10; 5.1 min: 90:10; 40 min: 30:70) On an Agilent ZORBAX SB-C18 column | Zhang C. E. et al., |
| UHPLC-MS | 21 biomarkers | sphingolipid metabolim and tricarboxylic acid cycle | Rats. p.o., different extracts of PM, blood samples | Eluted with H2O: CH3CN (both of them containing 0.1% HCOOH(0 min: 95:5; 1 min: 95:5; 9 min: 60:40; 19 min: 10:90; 21 min: 0:100; 25min: 0:100) On a ZORBOX RRHD C18 analytical column | Li et al., |